关注
Francesca Maria  Carozzi
Francesca Maria Carozzi
未知所在单位机构
在 unifi.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
G Ronco, P Giorgi-Rossi, F Carozzi, M Confortini, P Dalla Palma, ...
The lancet oncology 11 (3), 249-257, 2010
11952010
Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial
G Ronco, N Segnan, P Giorgi-Rossi, M Zappa, GP Casadei, F Carozzi, ...
Journal of the National Cancer Institute 98 (11), 765-774, 2006
4262006
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test
G Ronco, P Giorgi-Rossi, F Carozzi, M Confortini, PD Palma, A Del Mistro, ...
Journal of the National Cancer Institute 100 (7), 492-501, 2008
3802008
Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT
AL Pegna, G Picozzi, M Mascalchi, FM Carozzi, L Carrozzi, C Comin, ...
Lung cancer 64 (1), 34-40, 2009
3592009
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial
E Paci, D Puliti, AL Pegna, L Carrozzi, G Picozzi, F Falaschi, F Pistelli, ...
Thorax 72 (9), 825-831, 2017
3112017
Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial
G Ronco, P Giorgi-Rossi, F Carozzi, P Dalla Palma, A Del Mistro, ...
The Lancet Oncology 7 (7), 547-555, 2006
3022006
Categorizing breast mammographic density: intra-and interobserver reproducibility of BI-RADS density categories
S Ciatto, N Houssami, A Apruzzese, E Bassetti, B Brancato, F Carozzi, ...
The Breast 14 (4), 269-275, 2005
2862005
Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection
M Di Paola, C Sani, AM Clemente, A Iossa, E Perissi, G Castronovo, ...
Scientific reports 7 (1), 10200, 2017
2762017
Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial
F Carozzi, M Confortini, P Dalla Palma, A Del Mistro, A Gillio-Tos, ...
The lancet oncology 9 (10), 937-945, 2008
2572008
Eurogin roadmap 2017: triage strategies for the management of HPV‐positive women in cervical screening programs
K Cuschieri, G Ronco, A Lorincz, L Smith, G Ogilvie, L Mirabello, ...
International journal of cancer 143 (4), 735-745, 2018
1912018
Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested …
F Carozzi, A Gillio-Tos, M Confortini, A Del Mistro, C Sani, L De Marco, ...
The lancet oncology 14 (2), 168-176, 2013
1852013
The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600)
P Giorgi Rossi, LM Marsili, L Camilloni, A Iossa, A Lattanzi, C Sani, ...
British journal of cancer 104 (2), 248-254, 2011
1602011
Four-year results of low-dose CT screening and nodule management in the ITALUNG trial
AL Pegna, G Picozzi, F Falaschi, L Carrozzi, M Falchini, FM Carozzi, ...
Journal of Thoracic Oncology 8 (7), 866-875, 2013
1562013
Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples
MT Sandri, P Lentati, E Benini, P Dell'Orto, L Zorzino, FM Carozzi, ...
Journal of clinical microbiology 44 (6), 2141-2146, 2006
1492006
Reproducibility of HPV DNA testing by Hybrid Capture 2 in a screening setting: intralaboratory and interlaboratory quality control in seven laboratories participating in the …
FM Carozzi, AD Mistro, M Confortini, C Sani, D Puliti, R Trevisan, ...
American journal of clinical pathology 124 (5), 716-721, 2005
1192005
HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology
G Ronco, J Cuzick, N Segnan, S Brezzi, F Carozzi, S Folicaldi, ...
European Journal of Cancer 43 (3), 476-480, 2007
1132007
Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients
M Mangoni, S Bisanzi, F Carozzi, C Sani, G Biti, L Livi, E Barletta, ...
International Journal Of Radiation Oncology* Biology* Physics 81 (1), 52-58, 2011
1072011
Reduced and full-preparation CT colonography, fecal immunochemical test, and colonoscopy for population screening of colorectal cancer: a randomized trial
L Sali, M Mascalchi, M Falchini, L Ventura, F Carozzi, G Castiglione, ...
Journal of the National Cancer Institute 108 (2), djv319, 2016
1032016
Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors
G Ronco, A Biggeri, M Confortini, C Naldoni, N Segnan, M Sideri, ...
Epidemiologia e prevenzione 36 (3-4 Suppl 1), e1-72, 2012
101*2012
Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy
FM Carozzi, ML Tornesello, E Burroni, G Loquercio, G Carillo, C Angeloni, ...
Cancer epidemiology, biomarkers & prevention 19 (9), 2389-2400, 2010
832010
系统目前无法执行此操作,请稍后再试。
文章 1–20